685 related articles for article (PubMed ID: 16474154)
1. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
[TBL] [Abstract][Full Text] [Related]
2. Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment.
Nora T; Charpentier C; Tenaillon O; Hoede C; Clavel F; Hance AJ
J Virol; 2007 Jul; 81(14):7620-8. PubMed ID: 17494080
[TBL] [Abstract][Full Text] [Related]
3. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
4. Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy.
Brown AJ; Cleland A
AIDS; 1996 Sep; 10(10):1067-73. PubMed ID: 8874622
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia.
Martínez MA; Cabana M; Ibáñez A; Clotet B; Arnó A; Ruiz L
Virology; 1999 Apr; 256(2):180-7. PubMed ID: 10191182
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
[TBL] [Abstract][Full Text] [Related]
8. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
Cardoso LP; Queiroz BB; Stefani MM
J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 drug resistance in variants from the female genital tract and plasma.
Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
[TBL] [Abstract][Full Text] [Related]
11. Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1.
John M; Moore CB; James IR; Mallal SA
Antivir Ther; 2005; 10(4):551-5. PubMed ID: 16038481
[TBL] [Abstract][Full Text] [Related]
12. A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.
Garcia-Perez J; Sanchez-Palomino S; Perez-Olmeda M; Fernandez B; Alcami J
J Med Virol; 2007 Feb; 79(2):127-37. PubMed ID: 17177310
[TBL] [Abstract][Full Text] [Related]
13. Evidence for positive epistasis in HIV-1.
Bonhoeffer S; Chappey C; Parkin NT; Whitcomb JM; Petropoulos CJ
Science; 2004 Nov; 306(5701):1547-50. PubMed ID: 15567861
[TBL] [Abstract][Full Text] [Related]
14. High frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil.
de Oliveira CM; Almeida FJ; Rodrigues R; Crozatti M; Vazquez CM; do Socorro Carneiro Ferrão M; Campeas AE; Marques SR; Berezin EN; de Macedo Brígido LF
Arch Virol; 2008; 153(10):1799-806. PubMed ID: 18716710
[TBL] [Abstract][Full Text] [Related]
15. A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes.
Van Laethem K; Schrooten Y; Dedecker S; Van Heeswijck L; Deforche K; Van Wijngaerden E; Van Ranst M; Vandamme AM
J Virol Methods; 2006 Mar; 132(1-2):181-6. PubMed ID: 16271771
[TBL] [Abstract][Full Text] [Related]
16. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale.
Yahi N; Fantini J; Tourres C; Tivoli N; Koch N; Tamalet C
J Infect Dis; 2001 May; 183(9):1311-7. PubMed ID: 11294661
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
[TBL] [Abstract][Full Text] [Related]
18. Random important alterations in HIV-1 viral quasispecies after antiviral treatment.
Sánchez-Palomino S; Olivares I; Yuste E; Richman DD; López-Galíndez C
Antivir Ther; 1996 Dec; 1(4):225-36. PubMed ID: 11324825
[TBL] [Abstract][Full Text] [Related]
19. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
[TBL] [Abstract][Full Text] [Related]
20. A model of directional selection applied to the evolution of drug resistance in HIV-1.
Seoighe C; Ketwaroo F; Pillay V; Scheffler K; Wood N; Duffet R; Zvelebil M; Martinson N; McIntyre J; Morris L; Hide W
Mol Biol Evol; 2007 Apr; 24(4):1025-31. PubMed ID: 17272680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
